Intriguingly, co-targeting of β1 integrin/JNK mediated cytotoxicity and additive radiosensitization in GBM stem-like cells and PDC as well as GBM cell lines relative to controls and superior to monotherapies (Figure 1A–1C, Supplementary Table 2). This evidence concerns the gene MAPK8 and glioblastoma.